D and 6IB Related Headlines

Go Back

Mar 30, 2026 08:00PM Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edem

D and 6IB Related Press Releases

Go Back

Mar 30, 2026 08:00PM Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edem

D and 6IB Related SEC Filings

Go Back